Cite
HARVARD Citation
Roboz, G. et al. (2020). Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia. Leukemia & lymphoma. 61 (5), pp. 1188-1194. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Roboz, G. et al. (2020). Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia. Leukemia & lymphoma. 61 (5), pp. 1188-1194. [Online].